Fink, M., Vittrup, A. S., Bastholt, L., Svane, I. M., Donia, M., Luczak, A. A., . . . Schmidt, H. (2021). Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study. MDPI AG.
Cita Chicago Style (17a ed.)Fink, Morten, et al. Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study. MDPI AG, 2021.
Cita MLA (8a ed.)Fink, Morten, et al. Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study. MDPI AG, 2021.